Cardiol Therapeutics Inc.
General ticker "CRDL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $90.4M (TTM average)
Cardiol Therapeutics Inc. follows the US Stock Market performance with the rate: 14.4%.
Estimated limits based on current volatility of 5.4%: low 0.90$, high 1.00$
Factors to consider:
- Total employees count: 17 as of 2022
Short-term CRDL quotes
Long-term CRDL plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$29.79MM | CA$40.28MM |
| Operating Income | CA$-29.79MM | CA$-40.28MM |
| Non-Operating Income | CA$1.66MM | CA$3.60MM |
| R&D Expense | CA$14.22MM | CA$14.01MM |
| Income(Loss) | CA$-28.13MM | CA$-36.68MM |
| Profit(Loss)* | CA$-56.23MM | CA$-36.68MM |
| Stockholders Equity | CA$28.25MM | CA$24.73MM |
| Assets | CA$36.70MM | CA$31.86MM |
| Operating Cash Flow | CA$-0.03MM | CA$-25.06MM |
| Capital expenditure | CA$0.00MM | CA$0.02MM |
| Investing Cash Flow | CA$-0.00MM | CA$-0.02MM |
| Financing Cash Flow | CA$-0.00MM | CA$18.84MM |
| Earnings Per Share** | CA$-0.87 | CA$-0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.